Increasing Use Of Interferon Gamma Release Assays Among Children ≥2 Years of Age in a Setting With Low Tuberculosis Prevalence
Campbell JI, Tabatneck M, Sun M, He W, Musinguzi N, Hedt-Gauthier B, Lamb GS, Goldmann D, et al. (11 authors)
The Pediatric infectious disease journal · 2022-10
Abstract
US guidelines recommend interferon gamma release assays (IGRAs) for diagnosis of tuberculosis infection in children. In this retrospective cohort study, IGRA use in children 2-17 years of age increased substantially between 2015 and 2021. Testing in inpatient/subspecialty settings (vs. primary care), public (vs. private) insurance, lower age and non-English preferred language were associated with increased odds of receiving an IGRA.
MeSH terms
- Humans
- Mycobacterium tuberculosis
- Tuberculosis
- Tuberculin Test
- Prevalence
- Retrospective Studies
- Child
- Latent Tuberculosis
- Interferon-gamma Release Tests